Drug Pipeline

131I-IPA Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 1
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT05450744 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) Neoplastic Disease Recruiting
Not specified
NCT06474533 Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm Intracranial Neoplasm Recruiting
NCT07366710 Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients… Glucose Metabolism Active, Not Recruiting
NCT07475390 99mTc-1-thio-D-glucose SPECT/CT Versus 18F-Fluoroethyl-l-tyrosine PET/CT in Brain Tumor… Glioma (Any Grade) in the Brain Active, Not Recruiting
Sponsors Running 131I-IPA Trials
Disease Areas
Get alerts when 131I-IPA trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free